- Private equity firm Veritas Capital and hedge fund Elliott Management have agreed to acquire U.S. healthcare software maker Athenahealth for $5.5 billion in cash.
- Layoffs are sure to follow.
- HCP’s are not fond of Atenahealth’s cumbersome software.
- Republicans have indicated that they are willing to work with democrats on drug pricing initiatives.
- Drug companies are focusing lobbying efforts to use a possible lame-duck session of Congress to peel back a legislative loss they suffered earlier this year.
- Pharma is making a lobbying push to roll back seniors’ drug discounts at a time when they are reporting near record profits.
- So far in 2018, PhRMA spent more than $20 million, according to the Center for Responsive Politics, and was the third-largest spender.
- Content marketing when compared to paid search, gets three times the leads per dollar spent.
- Web sites publishing 16-plus posts a month get almost 3.5 times more traffic than businesses publishing zero to four articles.
- 60% of marketers create at least one piece of content each day.
- Online health seekers are overwhelmed with the mount of online health content and 85% would prefer to get all their questions answered on ONE site.
- 62 percent of cancer patients report being in debt due to their treatment.
55 percent accrue at least $10,000 in debt, while 3 percent file for bankruptcy.
- Almost 700,000 people in the U.S. declare bankruptcy due medical bills.
- American’s are sick and tired of a healthcare system that costs too much and provides too little.
Accenture wrote many years ago that the biggest challenge to the pharma industry was their own organizational shortcomings. Unfortunately, most big pharma companies haven’t got the message and to this day most employees are treated as expendable assets. Continue reading
- After reporting a 45% increase in quarterly profit Pfizer said “it’s business as normal”.
- Drug companies have made clear that they’ll never voluntarily reduce prices.
- The pharma industry has spent more than $216 million on lobbying this year.
- “Telling companies to voluntarily lower their prices and expecting it to happen on a consistent basis is not a realistic long-term policy proposition,” said Anthony T. LoSasso, a professor of health policy and administration at the University of Illinois at Chicago.
- Patients are skeptical of new prescription drugs.
- In addition to going to a pharma site they do a LOT of online research.
- Pharma sites are not meeting their needs when it comes the information they need to try or switch to new medications.
- People are using social media to learn about new medications, but the trust of others posts remains low.